MARINUS PHARMACEUTICALS, INC. - COMMON STOCK (MRNS)

CUSIP: 56854Q200

Q2 2022 13F Holders as of 30 Jun 2022

Holder snapshot 7 signals
Share change
-1,223,041
Put/Call ratio
116%
SEC-reported price per share
$4.84
Number of holders
67
Value change
-$7,995,233
Number of buys
27
Open additional details 1 more signal available
Number of sells
49
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
54,731,500

Security key

56854Q200

Report period

Q2 2022

Institutions

67

Top holders

10

Ownership snapshot

Top reported holders of MRNS - MARINUS PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Lion Point Capital, LP
Disclosed value leader
Lion Point Capital, LP
Comparable rows
0/15
Latest evidence
31 Mar 2022
13F Highest disclosed value: $33,936,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Lion Point Capital, LP has the largest disclosed position value at $33.94M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Lion Point Capital, LP's linked filing trail.
Disclosed position value Top 5
Lion Point Capital, LP $33.94M
Venrock Adviser, LLC $29.52M
Avoro Capital Advisors LLC $29.45M
MONTANOVA CAPITAL, LLC $25.86M
BlackRock Finance, Inc. $24.55M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Lion Point Capital, LP
13F
Company
13F
—
denominator unverified
$33,936,000
3,629,622 shares
— 31 Mar 2022
Venrock Adviser, LLC
13F
Company
13F
—
denominator unverified
$29,516,000
3,156,803 shares
— 31 Mar 2022
Avoro Capital Advisors LLC
13F
Company
13F
—
denominator unverified
$29,453,000
3,150,000 shares
— 31 Mar 2022
MONTANOVA CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$25,862,000
2,766,000 shares
— 31 Mar 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$24,553,000
2,626,028 shares
— 31 Mar 2022
683 Capital Management, LLC
13F
Company
13F
—
denominator unverified
$18,072,000
1,932,829 shares
— 31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
67
Shares
28,789,161
Rows available
67
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q3 2025 Across Filers

Q3 2025 holders
1
Q2 2022 holders
67
Holder diff
66
Investor Q3 2025 Shares Q2 2022 Shares Share Diff Share Chg % Q3 2025 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .